Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

NCT00326469

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • H. Juan Canalejo A Coruña, Spain
  • H. Virgen de los Lirios Alcoy, Spain
  • H. General Univ. de Alicante Alicante, Spain
  • H. Germans Trias i Pujol Badalona, Spain
View all 27 locations
View Trial Details
Completed

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

NCT01234168

Conditions
Carcinoid Syndrome, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +7 more
Locations
  • Teaching Hospital Brno Bohunice Brno, Czechia
  • University Hospital Hradec Kralove Hradec Králové, Czechia
  • Hospital Pardubice Pardubice, Czechia
  • Teaching Hospital Pilsen, Czechia
View all 57 locations
View Trial Details
Completed

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.

NCT02698410

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Oncologia Medica - Istituto Oncologico del Mediterraneo - IOM Viagrande, Catania, Italy
  • Unità Operativa di Oncologia Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l., IRCCS Meldola, Italy
  • Unità Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Istituto Europeo di Oncologia, IEO Milan, Italy
View Trial Details
Completed

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

NCT02402062

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Institut Catalá d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Provincial de Castellón Castellon, Valencia, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View Trial Details

Related conditions